Current Drug Targets


Francis J. Castellino
Kleiderer-Pezold Professor of Biochemistry
Director, W.M. Keck Center for Transgene Research
Dean Emeritus, College of Science
230 Raclin-Carmichael Hall, University of Notre Dame
Notre Dame, IN 46556


Meet Our Editorial Board Member: free to download

Volume:17   Issue:2
Pp: 137-137
Subhash C. Basu
DOI: 10.2174/138945011702160105145038

Order Reprints Order Eprints

Editorial (Thematic Issue: Targeting Defective DNA Damage Response Signaling) free to download

Volume:17   Issue:2
Pp: 138-138
Loredana Campo and Eun-Kyoung Breuer
DOI: 10.2174/138945011702160105145550

Order Reprints Order Eprints

The Role of JNK Signalling in Responses to Oxidative DNA Damage

Volume:17   Issue:2
Pp: 154-163
Zeeshan Shaukat, Dawei Liu, Rashid Hussain, Mahwish Khan and Stephen L. Gregory
DOI: 10.2174/1389450116666150126111055

Order Reprints Order Eprints

Nanocarriers Based Anticancer Drugs: Current Scenario and Future Perceptions

Volume:17   Issue:2
Pp: 206-228
Rakesh Raj, Pooja Mongia, Suresh Kumar Sahu and Alpana Ram
DOI: 10.2174/1389450116666150722141607

Order Reprints Order Eprints

The Use of Mesenchymal Stem Cells for the Treatment of Autoimmunity: From Animals Models to Human Disease

Volume:17   Issue:2
Pp: 229-238
Alessandra Fierabracci, Andrea Del Fattore, Marta Muraca, Domenico Vittorio Delfino and Maurizio Muraca
DOI: 10.2174/1389450116666150722140633

Order Reprints Order Eprints